MannKind to Participate in the Chardan Healthcare Conference
manilatimes.net · 2026-10-14
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), today announced that Chief Executive Officer Michael Castagna will participate in a panel focused on innovation across chronic respiratory diseases at the Chardan Healthcare Conference. Management will also participate in one-on-one meetings with investors during the conference.
TickrTrends take: MannKind's participation in the Chardan Healthcare Conference provides an opportunity for the company to present its business strategy and operational updates to investors and analysts in the healthcare sector. Given TickrTrends' current undervalued assessment of MNKD, this conference appearance may serve as a platform for the company to communicate developments that could influence how the market values its assets and future prospects. Valuation-focused investors should monitor any announcements regarding pipeline progress, commercial execution, or financial guidance that emerge from the company's participation in this industry forum.
Read the full story at manilatimes.net →
Is MNKD undervalued? See TickrTrends' fair value analysis →